AstraZeneca experimental lung cancer drug shows promising results

AstraZeneca’s experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Related Keywords

Japan , Ken Takeshita , Daiichi Sankyo , Susan Galbraith , Astrazeneca ,